In a B16 melanoma model, intratumoral (i.t.)VSV-NDV injection induced strong innate and adaptive immunity, with NK cell activation, DC maturation, and CD8+ T cells, which were shown to infiltrate into both treated and distant tumors and were essential for tumor control [42]. The gene discussed is CD8A; the disease is melanoma.